Company Filing History:
34 out of 151 
11 out of 1,177 
6 out of 2,480 
Years Active: 2013-2024
Title: Hanspeter Rottensteiner: Innovator in Gene Therapy
Introduction
Hanspeter Rottensteiner is a notable inventor based in Vienna, Austria, with an impressive portfolio of 34 patents to his name. His work primarily focuses on gene therapy, specifically related to treatments for genetic disorders such as hemophilia A. Through his innovative approaches, he has contributed significantly to the advancement of therapeutic methodologies.
Latest Patents
Rottensteiner’s recent patents highlight his cutting-edge research in gene therapy. Notably, he has developed a patent titled "Gene therapy of hemophilia A using viral vectors encoding recombinant FVIII variants with increased expression." This patent presents novel codon-altered polynucleotides designed for effective expression in mammalian cells. Furthermore, it outlines gene therapy vectors and practical methods for administering treatments to hemophilia A patients.
Another significant patent of his is concerning "Anti-factor IX Padua antibodies." This invention includes anti-Factor IX Padua binding constructs such as antibodies and their fragments, along with related polypeptides and kits. These innovations contribute to the detection methods for Factor IX Padua in biological samples, enhancing diagnostic capabilities in therapeutic settings.
Career Highlights
Throughout his career, Hanspeter Rottensteiner has been associated with prominent companies, including Baxalta GmbH and Takeda Pharmaceutical Company Limited. His work in these organizations has facilitated the translation of gene therapy from the laboratory to potential clinical applications, reflecting his commitment to improving patient care through scientific innovation.
Collaborations
Collaboration has been a key aspect of Rottensteiner's success. He has collaborated with notable colleagues, including Peter Turecek and Juergen Siekmann. These partnerships have enabled the exchange of ideas and expertise, further advancing the field of gene therapy.
Conclusion
Hanspeter Rottensteiner exemplifies the spirit of innovation in the realm of gene therapy. With his extensive patent portfolio and contributions to major pharmaceutical companies, he continues to pave the way for new treatment options for genetic disorders. His work not only enhances scientific understanding but also offers hope for improved therapies for patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.